Two cycles of dual neoadjuvant immunotherapy (nivolumab/ipilimumab or nivolumab/relatlimab) induced high pathological ...

Researchers at the Markey Cancer Center have made an important discovery that could lead to new treatments for ...

The event, which was part of the foundation’s annual Breast Cancer 5K Walk/Run, raised an event-high of more than $175,000 ...

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.

A vaccine against triple-negative breast cancer was found to produce an immune response and was well tolerated by most patients during an ongoing clinical trial. The findings will be presented by ...

University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...

Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing ...

For patients with operative triple-negative breast cancer, a multigene signature can help tailor adjuvant chemotherapy.

After surviving triple-negative breast cancer, Sara Flagstad gives back by mentoring through Firefly Sisterhood, supporting ...

Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...

Scientists have identified 16 genes that breast cancer cells use to survive in the bloodstream after they've escaped the low-oxygen regions of a tumor. Each is a potential therapeutic target to stop ...